US Stocks
/
Celldex Therapeutics, Inc. Share Price

Celldex Therapeutics, Inc. Share Price

NASDAQ: CLDX | Small Cap
$29.89
+$0.63 (2.15%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Celldex Therapeutics, Inc. Stock Performance

Open
$29.05
Prev. Close
$29.26
Circuit Range
N/A
Day Range
$29.04 - $30.25
Year Range
$22.21 - $45.07
Volume
78,362
Average Traded
$29.89

Celldex Therapeutics, Inc. Share Price Today

As of 11 October 2026, Celldex Therapeutics, Inc.'s share price is $29.89. The stock opened at $29.05, compared to its previous close of $29.26. During today's trading session, Celldex Therapeutics, Inc.'s share price traded between $29.04 and $30.25, with an average price of $29.64. Over the past 52 weeks, the stock has recorded a high of $45.07 and a low of $22.21. In terms of performance, Celldex Therapeutics, Inc.'s share price has declined by 9.07% over the last six months and is up 11.95% on a year-on-year basis.

Celldex Therapeutics, Inc. Share Price Chart

$29.04$30.25
L
Show Current Price
H

Celldex Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.99B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.83
Revenue (TTM)
$1.55B
Return On Equity (TTM)
-42.06%
Profit Margin
-16694.19%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-9.64%

Celldex Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.12$0.02$0.02
Net Profit-$67.04-$81.32-$78.69-$73.50
Net Profit MarginN/A-67766.67%-393450.00%-367500.00%
Income ChangeN/A-21.30%3.23%6.60%

Celldex Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2.36$6.88$7.02$1.55
Net Profit-$112.33-$141.43-$157.86-$258.76
Net Profit Margin-4759.75%-2055.67%-2248.72%-16694.19%
Income ChangeN/A-25.91%-11.62%-63.92%

About Celldex Therapeutics, Inc.

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Celldex Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$32.16
$29.86
-8.15%
Sep 2026
$39.22
$32.52
-19.52%
Aug 2026
$37.93
$40.40
+6.12%
Jul 2026
$37.35
$38.07
+2.41%
Jun 2026
$30.95
$37.17
+18.43%
May 2026
$33.43
$31.39
-4.50%
Apr 2026
$32.12
$32.87
+3.67%
Mar 2026
$29.72
$31.70
+5.30%
Feb 2026
$24.59
$30.11
+22.25%
Jan 2026
$27.03
$24.63
-9.32%
Dec 2025
$26.48
$27.16
+0.56%
Nov 2025
$26.63
$27.01
+1.16%

CLDX Share Price FAQs

What is Celldex Therapeutics, Inc. share price today?

chevron-up
Celldex Therapeutics, Inc. share price today is $29.89 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Celldex Therapeutics, Inc. stock?

chevron-up
The 52 week high of Celldex Therapeutics, Inc. stock is $45.07, while the 52 week low is $22.21 as of 10 Oct '26.

What is CLDX's market capitalisation today?

chevron-up
CLDX market capitalisation is $1.99B as of October 11, 2026, at 7:23 am IST.

What is CLDX's net income for the last quarter?

chevron-up
CLDX's net income for the last quarter is -73.50B USD.

What is the 5 year returns of CLDX?

chevron-up
The 5 year returns of CLDX is -29.75% as on 10 Oct '26.

What is the high & low stock price of CLDX today?

chevron-up
CLDX stock price hit a high of $30.25 and low of $29.04 as of 10 Oct '26.

Can I buy CLDX shares in India?

chevron-up
Yes. You can buy CLDX in India by opening an international trading account.